News & Perspective

Apr 08, 2013

Apr 08, 2013

CDC waiting for H7N9 sample to speed test kits

(CIDRAP News) – A human isolate of the novel H7N9 influenza virus from China—needed for the development of diagnostic test kits and related efforts—is expected to arrive at the Centers for Disease Control and Prevention (CDC) within 2 days, a CDC official said today.

Apr 01, 2013

Apr 01, 2013

China reports three H7N9 infections, two fatal

(CIDRAP News) – Chinese health officials yesterday announced three severe respiratory infections, two of them fatal, from H7N9 influenza, a subtype that has not been known to infect humans before.

Feb 15, 2013

Feb 15, 2013

CDC: Flu activity continues to slow

(CIDRAP News) – The nation's flu markers show that the flu has probably peaked, though many states are still reporting plenty of infections and hospitalizations, the US Centers for Disease Control and Prevention (CDC) said today.

Though the percentage of doctors' visits for influenza-like illness (ILI) is still above baselines in all regions of the country, the overall national level fell from 3.6% to 3.2% last week, according to the CDC.

Feb 17, 2011

Feb 17, 2011

WHO sticks with current strains for next flu vaccine

(CIDRAP News) – Signaling that the current flu strains are likely to persist over the next several months, the World Health Organization (WHO) today recommended sticking with the current trio of vaccine strains for the Northern Hemisphere's next influenza season.

The WHO's vaccine strain advisory committee met on Feb 15 and 16 and released its recommendation on the WHO's Web site. The group recommends the following for next season's vaccine:

Jan 18, 2011

Jan 18, 2011

Northern Hemisphere countries show steady rise in flu

(CIDRAP News) – Flu activity is increasing in many of the Northern Hemisphere's temperate-zone countries, with influenza B cocirculating with the 2009 pandemic H1N1 virus across Europe and teaming up with influenza A (H3N2) in the United States and Canada, the World Health Organization (WHO) said in its latest update.

Sep 10, 2010

Sep 10, 2010

Japan approves second new flu antiviral this year

(CIDRAP News) – Japan today approved a new long-acting influenza antiviral drug, Inavir (laninamivir), made by Daiichi Sankyo Co. Ltd., marking the second new flu drug licensed there this year.

Pages

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»